Literature DB >> 19147826

FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions.

Cécile Taflin1, Makoto Miyara, Dominique Nochy, Dominique Valeyre, Jean-Marc Naccache, Frédéric Altare, Pascale Salek-Peyron, Cécile Badoual, Patrick Bruneval, Julien Haroche, Alexis Mathian, Zahir Amoura, Gary Hill, Guy Gorochov.   

Abstract

Sarcoidosis is characterized by a disproportionate Th1 granulomatous immune response in involved organs. It is also associated with both peripheral and intratissular regulatory T cell (Treg) expansion. These cells exhibit powerful antiproliferative activity, yet do not completely inhibit the production of either tumor necrosis factor-alpha or interferon-gamma. The origin of the observed Treg amplification and, more importantly, its impact on the evolution of sarcoidosis remain unresolved issues. Here, we show that CD4(+)CD45RA(-)FoxP3(bright) Tregs proliferate and accumulate within granulomas. However, circulating and tissue Treg numbers are neither correlated with the dissemination of the disease nor correlated locally with the extent of granulomatous inflammation. Rather, we found a positive correlation between the presence of Tregs in renal granulomas and the degree of interstitial fibrosis (r = 0.46, P = 0.03, n = 20). Furthermore, Treg depletion accelerates in vitro granuloma growth in mononuclear cell cultures of healthy controls, but not in those from patients with active sarcoidosis. The results of this study show that although healthy Tregs suppress the initial steps of granuloma formation, they have no positive influence on sarcoidosis lesions. Our findings argue for a more preventive than curative effect of Tregs on inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147826      PMCID: PMC2630558          DOI: 10.2353/ajpath.2009.080580

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  T-lymphocytes and cytokines in sarcoidosis.

Authors:  Carlo Agostini; Alessia Meneghin; Gianpietro Semenzato
Journal:  Curr Opin Pulm Med       Date:  2002-09       Impact factor: 3.155

2.  Langhans giant cells from M. tuberculosis-induced human granulomas cannot mediate mycobacterial uptake.

Authors:  G Lay; Y Poquet; P Salek-Peyron; M-P Puissegur; C Botanch; H Bon; F Levillain; J-L Duteyrat; J-F Emile; F Altare
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.

Authors:  Zoltán Fehérvári; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2004-11-01       Impact factor: 4.823

4.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis.

Authors:  Ling-Pei Ho; Britta C Urban; David R Thickett; Robert J O Davies; Andrew J McMichael
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

7.  Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death.

Authors:  Benedikt Fritzsching; Nina Oberle; Eva Pauly; Robert Geffers; Jan Buer; Johannes Poschl; Peter Krammer; Otwin Linderkamp; Elisabeth Suri-Payer
Journal:  Blood       Date:  2006-07-25       Impact factor: 22.113

8.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

10.  B cells and professional APCs recruit regulatory T cells via CCL4.

Authors:  R S Bystry; V Aluvihare; K A Welch; M Kallikourdis; A G Betz
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

View more
  40 in total

Review 1.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

Review 2.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

3.  Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.

Authors:  Douglas G Mack; Allison M Lanham; Michael T Falta; Brent E Palmer; Lisa A Maier; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

4.  Renal transplantation in patients with sarcoidosis: a French multicenter study.

Authors:  Jessie Aouizerate; Marie Matignon; Nassim Kamar; Eric Thervet; Christine Randoux; Bruno Moulin; Loic Raffray; Matthias Buchler; Emmanuel Villar; Mathieu Mahevas; Dominique Desvaux; Karine Dahan; Carine Diet; Vincent Audard; Philippe Lang; Philippe Grimbert
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 8.237

5.  Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells.

Authors:  Jaya Talreja; Harvinder Talwar; Nisar Ahmad; Ruchi Rastogi; Lobelia Samavati
Journal:  J Immunol       Date:  2016-07-11       Impact factor: 5.422

Review 6.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

7.  Quantitative in situ analysis of FoxP3+ T regulatory cells on transplant tissue using laser scanning cytometry.

Authors:  Hidenori Takahashi; Phillip Ruiz; Camillo Ricordi; Victor Delacruz; Atsushi Miki; Atsuyoshi Mita; Ryosuke Misawa; Scott Barker; George W Burke; Andreas G Tzakis; Hirohito Ichii
Journal:  Cell Transplant       Date:  2011-09-16       Impact factor: 4.064

Review 8.  Dendritic cell modulation as a new interventional approach for the treatment of asthma.

Authors:  Vincent Lombardi; Omid Akbari
Journal:  Drug News Perspect       Date:  2009-10

9.  Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.

Authors:  M M Imanguli; E W Cowen; J Rose; S Dhamala; W Swaim; S Lafond; B Yagi; R E Gress; S Z Pavletic; F T Hakim
Journal:  Leukemia       Date:  2014-02-28       Impact factor: 11.528

Review 10.  Genetic, Immunologic, and Environmental Basis of Sarcoidosis.

Authors:  David R Moller; Ben A Rybicki; Nabeel Y Hamzeh; Courtney G Montgomery; Edward S Chen; Wonder Drake; Andrew P Fontenot
Journal:  Ann Am Thorac Soc       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.